ReviewCureus2025

Cardiovascular Benefits of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Type 2 Diabetes Mellitus With Atherosclerotic Cardiovascular Disease: A Systematic Review of Randomized Controlled Trials.

Maria Ahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.